Department of Lymphoma, Sino-US Center for Lymphoma and Leukemia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Public Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Medical University, Tianjin 300060, China.
Mater Sci Eng C Mater Biol Appl. 2017 Oct 1;79:191-198. doi: 10.1016/j.msec.2017.05.046. Epub 2017 May 10.
The fluorescence-guided photothermal therapy (FPTT) has great potential in cancer treatment. However, the conventional FPTT has to be stimulated by external light, which tends to increase background noise and leads to the inaccurate infrared light irradiation for PTT. In this study, upconverting and persistent luminescent nanocarriers (UPLNs) loaded mesoporous silica nanoparticles (UPLNs@mSiO) were first designed to solve the problem mentioned above. The UPLNs cores can effectively reduce the short-lived autofluorescence interference by exerting the delay time between signal acquisition and pulsed excitation light. For testing the luminescence properties, the indotcyanine green (ICG) as photothermal agent was encapsulated into the UPLNs@mSiO. The experimental results showed that the UPLNs@mSiO nanoparticles could significantly reduce the short-lived autofluorescence interference and improve signal-to-noise ratio during FPTT. Our data suggest that UPLNs@mSiO may be a promising tool for improving the accuracy of PTT in vivo.
上转换和持续发光纳米载体(UPLNs)负载介孔硅纳米颗粒(UPLNs@mSiO)被首次设计用来解决上述问题。UPLNs 核可以通过在信号采集和脉冲激发光之间施加延迟时间,有效降低短寿命自体荧光的干扰。为了测试发光性能,将吲哚菁绿(ICG)作为光热剂封装到 UPLNs@mSiO 中。实验结果表明,UPLNs@mSiO 纳米颗粒可以显著降低 FPTT 过程中的短寿命自体荧光干扰,并提高信噪比。我们的数据表明,UPLNs@mSiO 可能是提高体内 PTT 准确性的一种有前途的工具。